Home » Trials » SLCTR/2021/021


A single-center, randomized, six month, parallel-group, study to compare the effectiveness of a combination of physiotherapy and Ayurveda treatment versus physiotherapy and placebo in ischemic stroke rehabilitation.

-

SLCTR Registration Number

SLCTR/2021/021


Date of Registration

26 Jul 2021

The date of last modification

Nov 11, 2024


View original TRDS


Trial Status



Application Summary


Scientific Title of Trial

A single-center, randomized, six month, parallel-group, study to compare the effectiveness of a combination of physiotherapy and Ayurveda treatment versus physiotherapy and placebo in ischemic stroke rehabilitation.


Public Title of Trial

Effectiveness of physiotherapy combined with standard Ayurveda treatments (a personalized treatment regime with a combination of Kashaya, Arishta, pills and oils) versus physiotherapy with placebo in improving functional activities in ischemic stroke patients: A Randomized Controlled Trial


Disease or Health Condition(s) Studied

Ischemic stroke


Scientific Acronym

None


Public Acronym

None


Brief title

Effectiveness of physiotherapy combined with Ayurveda treatments in ischemic stroke rehabilitation


Universal Trial Number

U1111-1268-0430


Any other number(s) assigned to the trial and issuing authority

ERC/2021/13: Rajarata University


Trial Details


What is the research question being addressed?

Is physiotherapy combined with Ayurveda treatment effective than physiotherapy and placebo in improving functional activities and ambulation in ischemic stroke patients?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Single blinded : Participants


Control

Placebo


Assignment

Parallel


Purpose

Treatment


Study Phase

Phase 2


Intervention(s) planned

-The study will be a randomized, participant blinded, placebo-controlled clinical trial. It will be conducted at the Ward 61 & 62, Professorial Unit, Teaching Hospital, Anuradhapura, Sri Lanka.

-Eligible participants will be randomized in to two groups (Control group or Experimental group) with a 1:1 allocation ratio by using minimization technique. Participants will remain blinded to treatment allocation until the outcomes are analyzed.

  • Experiment group (Group B) will undergo a combination of usual physiotherapy care and specific Ayurveda treatments. Ayurveda treatment regime consists of a patient individualized treatment protocol of oral medications (Kashaya, Arishta & Pills) and external application of herbal oils. All the Ayurveda drugs which will be used are in Ayurveda pharmacopoeia and are in current practice in government Ayurveda hospitals in Sri Lanka. Treatments will be continued up to six months.

-Control group (Group A) will undergo usual physiotherapy care with placebo Ayurveda treatments. Black tea will be used as placebo Kashaya and Arishta. Finger millet powder and wheat flour will be used to make placebo pills. Coconut oil will be used as placebo oils. Treatments will be continued up to six months.

Doses of interventions are as follows,

Physiotherapy All the exercises will be done for 5-15 repetitions, 2 sets with 10 seconds hold once a day for 5 consecutive days per week. Number of repetitions could be varying according to the individual’s disability level.

Ayurveda medications Kashaya • Denimba Kashaya • Dasamul Kashaya

Add 8 cups (2L) of Kashaya to 250 ml of water and boiled it until it reduces to 1 cup (250ml). Then, 125ml – mane 125 ml - nocte

Arishta • Dasa mul Arishtaya • Bala Arishtaya • Ashwagandha Arishtaya 12.5-25 ml tds

Pills • Yoga raja gugguluwa • Chandraprabha wati • Chandra kalkaya • Ashwagandha gruthaya • Thripala 1-2 pills tds (1 pill=5g)

Oils • Watha widuranga tahilaya • Mahanarayana thailaya • Ashwagandha thailaya

External application, massaging and fomenting of dorsal aspect of limbs of the affected side for 30 minutes on a daily basis.

Same dosing regimen will be used in the control group using the relevant placebo component.

Discharge plan (for both groups) Discharge will be decided by the on-call consultant physician (ward 61 & 62). There won’t be any extended hospital stay for the participants who are included in the study. After discharging, review visits and home treatment programs will be carried out.

-After discharging from the hospital, all participants will be advised to visit the hospital on two weekly bases until the completion of three months for follow up and at the end of three months, hospital follow up visits will be reduced to one visit per month till the completion of six months.

-All participants will be asked to continue their treatment program daily at home and adherence to treatment is checked by regular phone calls and by asking the patient to maintain a treatment diary.

-Ayurveda treatments will be given by a member in the study team who is a consultant physician and a diploma holder in Ayurveda and has registration in practicing Ayurveda and traditional medicine at Ayurveda Education and Hospital Board of Department of Ayurveda, under the Ministry of Health and Indigenous Medicine, Sri Lanka.

-Confirmation of the recruitment will be done by a consultant physician who is one of the members in the study team.


Inclusion criteria

• Patients confirmed to have an ischemic stroke • Patients above 18 years of age * Both men and women • Barthel Index 0-50 (severely disabled patients) • NIHSS score (The National Institutes of Health Stroke Scale Score) 5-20 on admission. • Non- thrombolysis patients


Exclusion criteria

• Stroke mimics (A nonvascular disease that presents with stroke-like symptoms, often indistinguishable from an actual stroke) Eg: brain tumors (gliomas, meningiomas, adenomas)

  • Toxic/ metabolic disorders ( hypoglycemia, hypercalcemia, hyponatremia, uremia, hepatic encephalopathy, hyperthyroidism, thyroid storm)
  • Infectious disorders (meningio encephalitis)
  • Psychological disorders
  • Migraines
  • Seizures
  • Demyelination disorders
    • Posterior circulation stroke • Hemorrhagic strokes • Patients without a caregiver, relative or a supporting family


Primary outcome(s)

1.

% change in global disability using Barthel Index

[

At the baseline, at the end of three months and six months of starting the treatments

]

Secondary outcome(s)

1.

% change in motor functions using the Motor Assessment Scale (MAS)

[

At the baseline, at the end of three months and six months of starting the treatments

]
2.

% change in risk of falls using the Berg Balance Scale (BBS)

[

At the baseline, at the end of three months and six months of starting the treatments

]
3.

% change in ability to walk independently using New Functional Ambulation Category (FAC)

[

At the baseline, at the end of three months and six months of starting the treatments

]
4.
[]
5.
[]

Target number/sample size

94 (47 in each arm)


Countries of recruitment

Sri Lanka


Anticipated start date

2021-07-30


Anticipated end date

2023-06-29


Date of first enrollment

2021-08-18


Date of study completion


Recruitment status

Terminated


Funding source

Research Grants Committee, Rajarata University of Sri Lanka


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2021-06-21


Approval number

ERC/2021/13


Details of Ethics Review Committee

Name: Ethics Review Committee of the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka
Institutional Address:Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura.
Telephone:+94 252053633
Email: ethicsreviewcommittee@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Y.M.N.M.Wickramasinghe
Temporary Lecturer
Faculty of Medicine and Allied Sciences Rajarata University of Sri Lanka Saliyapura.
0252227706
0714576313

nadeeshawick1987@gmail.com

Contact Person for Public Queries

Prof. Sisira Siribaddana
Senior Professor
Faculty of Medicine and Allied Health Sciences, Rajarata University of Sri Lanka Saliyapura
0252227706
0777326940

sisira.siribaddana@gmail.com


Primary study sponsor/organization

Higher degree, Research and Publication Committee

Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura.
0252234462
0252234464
deanfmas@yahoo.com

Secondary study sponsor (If any)







Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

No


IPD sharing plan description


Study protocol available

No


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results

Terminated.